OnCo
institutionsInstitution

Ontario Institute for Cancer Research

aka OICR

Ontario's provincially funded cancer research institute, which coordinated the International Cancer Genome Consortium and runs pancreatic cancer genomics trials.

Founded in 2005 and funded by the Government of Ontario, the Ontario Institute for Cancer Research in Toronto's MaRS Discovery District is a translational institute that hosted the secretariat and data coordination centre of the International Cancer Genome Consortium, with Lincoln Stein co-leading the Pan-Cancer Analysis of Whole Genomes. Steven Gallinger's COMPASS study brought real-time whole-genome sequencing to advanced pancreatic cancer, and Faiyaz Notta's work revealed how pancreatic tumours evolve. OICR runs drug discovery programmes (including WDR5 and other epigenetic targets), imaging and computational biology platforms, the Ontario Health Study and, through the FACIT commercialisation arm, spins out companies. It works closely with Princess Margaret and other Ontario centres.

Location
Toronto, ON, CA
Type
research institute
Website
Newsweek 2026 oncology rank
Not in top 300 listing used
OnCo score
#350 · 20 points (0 Newsweek + 0 NCI + 20 from 10 linked objects) · ranking

Programmes

4top
  • Cancer genomics (ICGC, PCAWG)
  • Pancreatic cancer (COMPASS)
  • Drug discovery
  • Commercialisation (FACIT)

Connected

10top

Pages like this

not linked directly; found by shared links